Clinically proven LED phototherapy — three wavelengths, one device. Charges cells. Heals tissue. No downtime, no pain, no recovery. Just light that works.
Dermalux MD MK II is the world's leading clinical LED phototherapy device — used in hospitals, research facilities and specialist clinics across the UK and internationally. It delivers three precisely calibrated wavelengths of light simultaneously, each targeting a different biological process within the skin and underlying tissue.
Unlike consumer LED devices, the MD MK II is a Class IIa medical device — CE marked, FDA cleared and MHRA registered. The clinical evidence base spans over 3,000 published studies. The results are measurable, documented and reproducible.
The Dermalux MD MK II simultaneously emits blue, red and near-infrared light — each penetrating to a different depth, each triggering a different cellular response. No other device does all three at medical-grade intensity in a single treatment.
Blue light at 415nm targets and destroys the acne-causing bacteria Cutibacterium acnes within the follicle. Clinically proven for acne vulgaris — without antibiotics, without irritation, without systemic side effects.
Red light at 633nm stimulates fibroblast activity, triggering new collagen and elastin production. It reduces inflammation, accelerates wound healing and delivers the cell renewal at a rate Dermalux documents as 200% above baseline.
Near-infrared at 830nm penetrates below the dermis into muscle and joint tissue. It reduces musculoskeletal pain, aids wound healing at depth, and is used clinically for conditions including psoriasis, rosacea and chronic inflammation.
Clinically calibrated wavelengths delivered across the skin — a relaxing, completely comfortable treatment with no heat and no downtime.
Watch blue, red and near-infrared light reach different depths — each triggering its own cellular response.